12/10/2018 16:49:00

Issue of Equity

Worldwide Healthcare Trust Plc - Issue of Equity

PR Newswire

WORLDWIDE HEALTHCARE TRUST PLC

12 October 2018

Allotment of Ordinary Shares

WORLDWIDE HEALTHCARE TRUST PLC (the “Company”) announces the allotment of 17,000 Ordinary shares of 25p each fully paid from its block listing authority dated 18 December 2017.  

These Ordinary shares were issued today at a price of 2603.25 pence per share, which equates to a premium to the estimated cum income net asset value at the time of transaction of 0.7%.  The cum income net asset value per Ordinary share at the close of business on 11 October 2018 was 2540.33 pence per share.

Following this issue, the Company has the ability to issue a further 929,977 shares under this block listing authority.

Following this transaction the Company hereby notifies the market that it has in issue 50,857,778 Ordinary shares of 25p each all with voting rights.  No shares were held in treasury at the date of announcement.

The figure of 50,857,778 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries:

Mark Pope                 

Frostrow Capital LLP            

Tel: 020 3 008 4913

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
07 Dec
VELO
Nedenfor vil jeg give et overblik over hvorfor jer er aktionær. Jeg tager måske fejl med mine antage..
38
07 Dec
VELO
CANADA godkendelse (ENDO)   Jeg lovede i en tråd for 2 uger siden at undersøge hvornår vi kan forven..
36
06 Dec
SAS-DKK
SAS aktien har fået kursklø efter et flot og fornemt regnskab, ledelsen vil ikke give budget for reg..
32
08 Dec
VELO
Havde igår en lang snak med min kapitalforvalter emnet - hvordan er det gået Hr og Fru Danmark's por..
27
06 Dec
VELO
  Man kan ikke være i tvivl om formålet med nyt afsnit, samt formuleringen i overskriften, når man s..
16
10 Dec
VELO
Når man følger Veloxis-debatten, og det hr jeg gjort i mange, mange år - også da den hed LCP, så går..
15
10 Dec
I:DAX
Det der foregår har da absolut intet med et flash crash at gøre ! Lad dog være med at brug fine bete..
15
10 Dec
 
Klart, klart... et firma, der reklamerer må være desperat. Personligt synes jeg ikke Pandora har n..
15
05 Dec
DANSKE
Danske bank er ikke mere kriminel end en politibetjent der ikke anholder en butikstyv.
14
06 Dec
 
Dette er hvad jeg kan læse, inden betalingsmuren sænker sig: Berlingske Media skruer op for ambition..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
2
Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
3
Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
4
WISeKey Secures Printer Systems, from Cartridge to Cloud, with WISePrint@Cloud
5
Flame Seal Products FS-PG Wildfire Protection System Proves Totally Effective in Raging California Wildfire

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 03:16:54
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB3 - 2018-12-11 04:16:54 - 2018-12-11 03:16:54 - 1000 - Website: OKAY